<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Myocardial Dysfunction and Adrenergic Cardiac Innervation in Patients With Insulin-Dependent Diabetes Mellitus
2
Myocardial Dysfunction Caused by Perinatal Asphyxia in Full-term Infants
3
Myocardial Dysfunction in Thalassemia Major: Comparison between Echocardiography and MRI
4
Myocardial dysfunction with coronary microembolization: Signal transduction through a sequence of no, TNFα and sphingosine
5
Myocardial Dysfunction: A Primary Cause of Death Due To Severe Malaria in A Plasmodium falciparum-Infected Humanized Mouse Model.
6
Myocardial dysfunction: hibernation and remodelling
7
Myocardial dysfunction: hibernation and remodelling
8
Myocardial edema: Comparison of effects on filling volume and stiffness of the left ventricle in rats and pigs
9
Myocardial effects of experimental acute brain death: Evaluation by hemodynamic and biological studies
10
Myocardial Effects of PDE5 Inhibition: More Function With Less Mass
11
Myocardial electrical impedance responds to ischemia and reperfusion in humans
12
Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease
13
Myocardial enterovirus infection with left ventricular dysfunction: benign disease compared with idiopathic dilated cardiomyopathy
14
Myocardial epithelial inclusions in a Holstein calf
15
Myocardial Expression Levels of Micro-Ribonucleic Acids in Patients With Left Ventricular Assist Devices: Signature of Myocardial Recovery, Signature of Reverse Remodeling, or Signature With No Name?
16
Myocardial Expression of Endothelin-1 in Murine Trypanosoma cruzi Infection
17
Myocardial Expression of Fas and Recovery of Left Ventricular Function in Patients With Recent-Onset Cardiomyopathy Original Research Article
18
Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat
19
Myocardial Extracellular Matrix Remodeling with the Development of Pacing Induced Congestive Heart Failure: Contributory Mechanisms
20
Myocardial Extracellular Remodeling Is Associated With Ventricular Diastolic Dysfunction in Children and Young Adults With Congenital Aortic Stenosis
21
Myocardial Extracellular Volume by Cardiac Magnetic Resonance Imaging in Patients Treated With Anthracycline-Based Chemotherapy
22
Myocardial extramedullary hematopoiesis following myocardial infarction
23
Myocardial factor for timing of surgery in asymptomatic patients with mitral regurgitation
24
Myocardial fibrin deposits in the first month after transplantation predict subsequent coronary artery disease and graft failure in cardiac allograft recipients
25
Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with
26
Myocardial Fibrosis Associated with Aldosterone or Angiotensin II Administration: Attenuation by Calcium Channel Blockade
27
Myocardial fibrosis detected by cardiac magnetic resonance imaging in heart failure: impact on remodeling, diastolic function and BNP levels
28
Myocardial Fibrosis Identified by Cardiac Magnetic Resonance Late Gadolinium Enhancement Is Associated With Adverse Ventricular Mechanics and Ventricular Tachycardia Late After Fontan Operation
29
Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone
30
Myocardial Fibrosis in Transforming Growth Factor β1Heterozygous Mice
31
Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death
32
Myocardial Flow Reserve in Long-Term Survivors of Repair of Anomalous Left Coronary Artery From Pulmonary Artery
33
Myocardial flow reserve in patients with a systemic right ventricle after atrial switch repair
34
Myocardial function and geometry in hypertensive subjects with low levels of afterload
35
Myocardial Function in Egyptian Pediatric Patients With Acute Nephritic Syndrome
36
Myocardial function in hearts with transgenic overexpression of the G protein-coupled receptor kinase 5
37
Myocardial function in patients with multiple sclerosis treated with low-dose mitoxantrone
38
Myocardial Function in the Working Mouse Heart Overexpressing Cardiac A1Adenosine Receptors
39
Myocardial Function of Horses Under Sedation with Romifidine Using Two-Dimensional Speckle Tracking
40
Myocardial Function of Hyperthyroid Rats in Presence of Diazepam in Langendorff Setup
41
Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging
42
Myocardial Gene Expression in Heart Failure Patients Treated With Cardiac Resynchronization Therapy: Responders Versus Nonresponders Original Research Article
43
Myocardial gene expression of inflammatory cytokines after heart transplantation in relation to the development of transplant coronary artery disease
44
Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: Comparison with surgical and percutaneous intramyocardial gene delivery Original Research Article
45
Myocardial Glucose Transport and Utilization in Patients With Type 2 Diabetes Mellitus, Left Ventricular Dysfunction, and Coronary Artery Disease Original Research Article
46
Myocardial Glucose Transporter GLUT1: Translocation Induced by Insulin and Ischemia
47
Myocardial Glycogen Depletion Cannot Explain the Cardioprotective Effects of Ischemic Preconditioning in the Rat Heart
48
Myocardial high-energy phosphate metabolism in patients with stable chronic dilated cardiomyopathy under a dobutamine-induced prolonged mild workload,
49
Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines
50
Myocardial Hydatid Cyst : An Uncommon Complication of Echinococcal Infection
51
Myocardial hydrophilic polymer emboli following cardiac catheterization: a case report and literature review
52
Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats
53
Myocardial IL-6 regulation by neurohormones—an in vitro superfusion study
54
Myocardial imaging in patients with defibrillator patch electrodes
55
Myocardial imaging with a new transpulmonary lipid-fluorocarbon echo contrast agent: Experimental studies in pigs
56
Myocardial immediate early gene activation after cardiopulmonary bypass with cardiac ischemia-reperfusion
57
Myocardial indium-111 antimyosin uptake after uncomplicated coronary artery bypass surgery
58
Myocardial infarction after an ice-hockey match: Coincidence of myocardial bridging and coronary spasm
59
Myocardial infarction after aspirin cessation in stable coronary artery disease patients
60
Myocardial Infarction after Endoscopic Removal of Foreign Body
61
Myocardial Infarction After Oral Sumatriptan Use in a Woman with Normal Coronary Arteries
62
Myocardial infarction after partial left ventriculectomy
63
Myocardial infarction after partial left ventriculectomy: Reply
64
Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging Original Research Article
65
Myocardial infarction after vascular surgery: the role of prolonged, stress-induced, ST depression-type ischemia
66
Myocardial infarction and coronary care units
67
Myocardial infarction and depression: A review article
68
Myocardial infarction and heart failure—a dangerous intersection
69
Myocardial infarction and HELLP: a case of heightened vasomotor reactivity
70
Myocardial Infarction and Hyperglycemia
71
Myocardial infarction and ischemia
72
Myocardial infarction and left ventricular remodeling: Results of the CEDIM trial
73
Myocardial infarction and percent arteriographic stenosis of culprit lesion: Report from the Program on the Surgical Control of the Hyperlipidemias (POSCH) Original Research Article
74
Myocardial Infarction and Regulatory Myosin Light Chain
75
Myocardial infarction and sub-acute ventricular rupture: successful outcome in two cases
76
Myocardial infarction and venous thrombosis in a 42-year old woman with heterozygous methylenetetrahydrofolate reductase (MTHRF) gene mutation, hyperhomocysteinemia, and protein C deficiency
77
Myocardial infarction as a complication of new interventional devices
78
Myocardial infarction as complication of left atrial myxoma
79
Myocardial infarction caused by a large coronary artery aneurysm
80
Myocardial infarction caused by a leukemic clot: A case report
81
Myocardial Infarction Caused by Active-Fixation Ventricular Pacing Lead Screwed into the Anterior Descending Coronary Artery
82
Myocardial infarction caused by compression of the left coronary artery by an aortic pseudoaneurysm
83
Myocardial infarction caused by coronary artery myocardial bridge,
84
Myocardial infarction complicating the initial phase of an ovarian stimulation protocol
85
Myocardial infarction diagnosis by morphology of ventricular extrasystole
86
Myocardial infarction due to lightning strike
87
Myocardial infarction during menses: lessons from trials and errors
88
Myocardial infarction during scuba diving: A case report and review
89
Myocardial Infarction Elevates Inflammation and Contributes to the Formation of Atheroma Plaques in the Aorta of Hypercholesterolaemic Rats
90
Myocardial infarction following a bee sting
91
Myocardial infarction in a 35-day-old infant with incomplete Kawasaki disease and chicken pox
92
Myocardial Infarction in a newborn from a diabetic mother
93
Myocardial Infarction in a Patient with Prosthetic Aortic Valve
94
Myocardial infarction in a patient with thrombotic thrombocytopenic purpura
95
Myocardial infarction in a woman with no apparent risk factors
96
Myocardial infarction in a young athlete with non-obstructive hypertrophic cardiomyopathy and normal coronary arteries
97
Myocardial Infarction in a Young Patient After Acute Exposure to Carbon Monoxide
98
Myocardial infarction in a young woman with antiphospholipid syndrome
99
Myocardial infarction in children
100
Myocardial Infarction in Iran: Epidemiology, Management, and Prognosis
101
Myocardial infarction in isolated ventricular non-compaction: Contrast echo and MRI
102
Myocardial infarction in mice: Functional characterization and cytokine expression
103
Myocardial Infarction in Newly Diagnosed Hypertensive Medicaid Patients Free of Coronary Heart Disease and Treated with Calcium Channel Blockers
104
Myocardial Infarction in Patients with and without COVID-19: Comparisons of Characteristics, Clinical Courses, and Outcomes
105
Myocardial infarction in pregnant women — Case reports
106
Myocardial infarction in pre-war Leeds
107
Myocardial infarction in pre-war Leeds
108
Myocardial infarction in pre-war Leeds
109
Myocardial infarction in sickle-cell disease
110
Myocardial Infarction in the Absence of Obstructive Epicardial Coronary Disease
111
Myocardial infarction in the C57BL/6J mouse: A quantifiable and highly reproducible experimental model
112
Myocardial infarction in young adults: Angiographic characterization, risk factors and prognosis (coronary artery surgery study registry)
113
Myocardial infarction in young adults: Angiographic characterization, risk factors, and prognosis (Coronary Artery Surgery Study registry): Zimmerman FH, Cameron A, Fisher LD, et al J Am Coll Cardiol 26:654–661 September 1995
114
Myocardial infarction in young patients
115
Myocardial Infarction Induced by Migraine Therapy
116
Myocardial infarction occurrence in Jerusalem: a Mediterranean anomaly
117
Myocardial infarction or inflammation?
118
Myocardial infarction patients in the 1990s—their risk factors, stratification and survival in Canada: The Canadian assessment of myocardial infarction (CAMI) study
119
Myocardial infarction postpartum in patients taking bromocriptine for the prevention of breast engorgement
120
Myocardial infarction quantification with late gadolinium-enhanced magnetic resonance imaging in rats using a 7-T scanner
121
Myocardial infarction redefined: Impact on case-load and outcome of patients with suspected acute coronary syndrome and nondiagnostic ECG at presentation
122
Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction: The Joint European Society of Cardiology/ American College of Cardiolo
123
Myocardial Infarction Resulting From Caffeine Overdose in an Anorectic Woman, ,
124
Myocardial infarction resulting from nonatherosclerotic coronary artery diseases
125
Myocardial infarction risk in relation to zinc concentration in toenails
126
Myocardial infarction scar plication in the rat: cardiac mechanics in an animal model for surgical procedures
127
Myocardial Infarction Secondary to a Coronary Ostial Thrombus in Antiphospholipid Syndrome
128
Myocardial Infarction Secondary to Inflammatory Myofibroblastic Tumor Obstruction of the Left Main: Treated With Primary PCI
129
Myocardial infarction with huge mural thrombus due to spontaneous coronary artery dissection detected by 64-multidetector computed tomography
130
Myocardial infarction with spontaneous reperfusion in a young woman with hypertrophic cardiomyopathy
131
Myocardial infarction with thrombus formation during prolonged intense exercise
132
Myocardial infarction without coronary artery occlusion following mental stress
133
Myocardial infarction, Arg 506 to Gin factor V mutation, and activated protein C resistance
134
Myocardial infarction, ventricular remodeling, and angiotensin-converting enzyme inhibition: Where we stand today
135
Myocardial Infarction, Viral Infection, and the Cytoskeleton: Final Common Pathways of a Common Disease?
136
Myocardial infarction: a catabolic disease?
137
Myocardial infarction: a paradigm of success in modern medicine
138
Myocardial infarction: a rare complication of dothiepin overdose
139
Myocardial infarction: changing view of a killer
140
Myocardial infarction: From trials to practice : Ball SG (editor) Wrightson Biomedical Publishing Ltd., Hampshire, UK, 1995; 194 pp.; stg£32.50; ISBN 1-871816-26-2
141
Myocardial infarction: is evidence-based medicine the best?
142
Myocardial Infarction-triggered Thrombotic Microangiopathy
143
Myocardial inflammatory infiltrate in human chronic chagasic cardiomyopathy: Immunohistochemical findings
144
Myocardial Injury After Electrical Therapy for Cardiac Arrhythmias Assessed by Troponin-T Release
145
Myocardial injury during off-pump surgery. The effect of intraoperative risk factors
146
Myocardial injury in thrombotic thrombocytopenic purpura: A frequent, perplexing complication
147
Myocardial injury, neurohormonal activation and inflammation after internal atrial defibrillation
148
Myocardial injury-related changes in plasma NT-proBNP and ANP concentrations in a canine model of ischemic myocardial injury
149
Myocardial integrated ultrasonic backscatter in patients with dilated cardiomyopathy: Prediction of response to β-blocker therapy
150
Myocardial integrated ultrasonic backscatter in patients with old myocardial infarction: Comparison with radionuclide evaluation
151
Myocardial involvement in a patient with human ehrlichiosis
152
Myocardial involvement in Takayasu arteritis
153
Myocardial Iodine-123 Meta-Iodobenzylguanidine Imaging and Cardiac Events in Heart Failure: Results of the Prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) Study
154
Myocardial iron load measured by cardiac magnetic resonance imaging to evaluate cardiac systolic function in thalassemia
155
Myocardial ischaemia
156
Myocardial ischaemia un-masked by transesophageal atrial pacing combined with two-dimensional transthoracic echocardiography in a pediatric patient: a case report
157
Myocardial ischaemia with a normal coronary angiogram due to the primary antiphospholipid syndrome
158
Myocardial Ischemia Activates the JAK–STAT Pathway Through Angiotensin II Signaling in in vivo Myocardium of Rats
159
Myocardial ischemia and autonomic activity in dippers and non-dippers with coronary artery disease: assessment of normotensive and hypertensive patients
160
Myocardial Ischemia and Infarction Review Article
161
Myocardial ischemia and infarction Review Article
162
Myocardial Ischemia and Infarction Review Article
163
Myocardial ischemia and reperfusion injury
164
Myocardial ischemia and ventricular fibrillation: Pathophysiology and clinical implications
165
Myocardial Ischemia and Ventricular Tachycardia on Continuous Electrocardiographic Monitoring and Risk of Cardiovascular Outcomes After Non–ST-Segment Elevation Acute Coronary Syndrome (from the MERLIN-TIMI 36 Trial)
166
Myocardial ischemia caused by a coronary anomaly left anterior descending coronary artery arising from right sinus of Valsalva
167
Myocardial Ischemia Caused by an Abnormal Origin and Course of the Left Coronary Artery in an Adult
168
Myocardial ischemia caused by cold-water submersion
169
Myocardial ischemia caused by external compression due to shotgun bullets
170
Myocardial ischemia due to coronary artery spasm during dobutamine stress echocardiography
171
Myocardial ischemia during physical exercise in patients with stable coronary artery disease: predictability and prevention
172
Myocardial ischemia during sexual activity in patients with coronary artery disease
173
Myocardial ischemia in generalized coronary artery–left ventricular microfistulae
174
Myocardial Ischemia Induced by Rapid Atrial Pacing Causes Troponin T Release Detectable by a Highly Sensitive Assay: Insights From a Coronary Sinus Sampling Study
175
Myocardial ischemia induced by topical use of 5-fluorouracil
176
Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process
177
Myocardial Ischemic Injury and Purine Metabolism in Patients Undergoing Coronary Artery Bypass
178
Myocardial ischemic injury during cardiopulmonary by-pass: Evaluation of purine compounds by capillary electrophoresis
179
Myocardial ischemic post-conditioning protects the lung against myocardial ischemia/reperfusion-induced damage by activating GSK-3β
180
Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome
181
Myocardial kinematics from tagged MRI based on a 4-D B-spline model
182
Myocardial Kinetics of 99mTechnetium-Q Agents Studies in Isolated Cardiac Myocyte, Isolated Perfused Rat Heart, and Canine Regional Myocardial Ischemia Models
183
Myocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion
184
Myocardial lactate dehydrogenase subunit ratio in cardiac allograft recipients
185
Myocardial laser revascularization for the treatment of end-stage coronary artery disease
186
Myocardial laser revascularization: the controversy and the data
187
Myocardial Late Enhancement in Duchenne and Becker Individuals in the Clinical Milieu
188
Myocardial Metabolic Abnormality in a Primary Left Atrial Rhabdomyosarcoma: Localized 1H MR Spectroscopy
189
Myocardial metabolism and hemodynamics during coronary surgery without cardiopulmonary bypass
190
Myocardial Metabolism is Better Preserved After Blood Cardioplegia in Infants
191
Myocardial microvascular abnormalities observed by intravenous myocardial contrast echocardiography in patients with hypertrophic cardiomyopathy
192
Myocardial mitochondrial calcium accumulation modulates nuclear calcium accumulation and DNA fragmentation
193
Myocardial Motion Analysis From B-Mode Echocardiograms
194
Myocardial myotonia in myotonic muscular dystrophy
195
Myocardial necrosis in “pure unstable angina”: Identification of high-risk subgroups or a contradiction in terms?, ,
196
Myocardial neutrophil infiltration, lipid peroxidation, and antioxidant activity after coronary artery thrombosis and thrombolysis
197
Myocardial No-Reflow in Humans
198
Myocardial outflow of prostacyclin in relation to metabolic stress during off-pump coronary artery bypass grafting
199
Myocardial Oxygen Consumption Modulates Adenosine Formation by Canine Right Ventricle in Absence of Hypoxia
200
Myocardial oxygen consumption: The quest for its determinants and some clinical fallout
201
Myocardial oxygen consumption: the quest for its determinants and some clinical fallout
202
Myocardial Oxygen Tension and Relative Capillary Density in Isolated Perfused Rat Hearts
203
Myocardial Oxygen Tension in Isolated Erythrocyte-perfused Rat Hearts and Comparison with Crystalloid Medi
204
Myocardial Oxygenation During Terminal Warm Blood Cardioplegia
205
Myocardial Oxygenation in Coronary Artery Disease: Insights From Blood Oxygen Level–Dependent Magnetic Resonance Imaging at 3 Tesla
206
Myocardial parasite persistence in chronic chagasic patients
207
Myocardial pathological changes in overtraining exercise
208
Myocardial perforation associated with the use of the Gensini ventriculography catheter
209
Myocardial performance after graft preservation and subsequent cardiac transplantation from brain-dead donors
210
Myocardial performance after successful intervention for native aortic coarctation
211
Myocardial Performance after Successful Liver Transplantation
212
Myocardial perfusion abnormalities during low-dose dobutamine after coronary reperfusion can be demonstrated with intravenous perfluorocarbon-exposed sonicated dextrose albumin ultrasound contrast
213
Myocardial perfusion abnormality and necrosis in a patient with isolated noncompaction of the ventricular myocardium: Evaluation by myocardial perfusion SPECT and magnetic resonance imaging
214
Myocardial perfusion and fatty acid metabolism in patients with tako-tsubo-like left ventricular dysfunction
215
Myocardial perfusion and function of the systemic right ventricle in patients after atrial switch procedure for complete transposition: long-term follow-up
216
Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy
217
Myocardial Perfusion and Ventricular Function Assessed by SPECT and Gated-SPECT in End-Stage Renal Disease Patients before and after Renal Transplant
218
Myocardial perfusion and viability by positron emission tomography in infants and children with coronary abnormalities: correlation with echocardiography,coronary angiography, and histopathology
219
Myocardial perfusion assessment in patients with medium probability of coronary artery disease and no prior myocardial infarction: comparison of myocardial contrast echocardiography with 99mTc single-photon emission computed tomography
220
Myocardial perfusion before and after single routine LDL-apheresis
221
Myocardial perfusion during warm antegrade and retrograde cardioplegia: a contrast echo study
222
Myocardial perfusion grade and survival after percutaneous transluminal coronary angioplasty in patients with cardiogenic shock
223
Myocardial Perfusion Imaging and Multidetector Computed Tomographic Coronary Angiography: Appropriate for All Patients With Suspected Coronary Artery Disease?
224
Myocardial Perfusion Imaging During Adenosine-Induced Coronary Hyperemia
225
Myocardial perfusion imaging findings and the role of adenosine in the warm-up angina phenomenon  
226
Myocardial perfusion imaging following percutaneous coronary intervention: the importance of restenosis, disease progression, and directed reintervention Review Article
227
Myocardial Perfusion Imaging Study of CO2-Induced Panic Attack
228
Myocardial perfusion imaging with technetium-99m sestamibi in patients with cocaine-associated chest Pain
229
Myocardial perfusion in apical ballooning syndrome: Correlate of myocardial injury
230
Myocardial perfusion in children with sickle cell disease
231
Myocardial perfusion in patients with permanent ventricular pacing and normal coronary arteries  
232
Myocardial perfusion in real-time using power modulation: In vivo evidence for microcirculatory damage after acute myocardial infarction
233
Myocardial perfusion magnetic resonance imaging for detecting coronary function anomalies in asymptomatic paediatric patients with a previous arterial switch operation for the transposition of great arteries
234
Myocardial Perfusion Magnetic Resonance Imaging Using Sliding-Window Conjugate-Gradient Highly Constrained Back-Projection Reconstruction for Detection of Coronary Artery Disease
235
Myocardial perfusion pattern in patients with cocaine-induced chest pain
236
Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy
237
myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging
238
Myocardial Perfusion Scintigraphy (Gated-SPECT) and Coronary Disease Risk Factors in Behçet’s Disease with Metabolic Syndrome
239
Myocardial Perfusion Scintigraphy and Value in Patients With Non-ST Segment Elevation Acute Coronary Syndromes
240
Myocardial perfusion single photon computed tomography: An Atlas
241
Myocardial perfusion SPECT and dobutamine stress tissue Doppler imaging in evaluation of patients with stable angina pectoris
242
Myocardial Perfusion SPECT Imaging in Dextrocardia with Situs Inversus: A Case Report
243
Myocardial perfusion SPECT: Perfusion quantification
244
Myocardial Perfusion Study of Panic Attacks in Patients With Coronary Artery Disease
245
Myocardial positron emission computed tomographic images obtained with fluorine-18 fluoro-2-deoxyglucose predict the response of idiopathic dilated cardiomyopathy patients to beta-blockers Original Research Article
246
Myocardial Preconditioning Produced by Ischemia, Hypoxia, and a KATPChannel Opener: Effects on Interstitial Adenosine in Dogs
247
Myocardial preservation during coronary surgery with and without cardiopulmonary bypass
248
Myocardial preservation using celsior solution in cardiac transplantation: early results and 5-year follow-up of a multicenter prospective study of 70 cardiac transplantations
249
Myocardial protection
250
Myocardial protection and esmolol in blood perfused rat hearts  
251
Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor
252
Myocardial protection during antegrade versus retrograde cardioplegia
253
Myocardial Protection During Elective Coronary Artery Bypass Grafting Using High-Dose Insulin Therapy
254
Myocardial protection during reperfusion by administration of caspase-3 inhibitor is mediated via PI3 kinase survival pathway  
255
Myocardial protection evoked by hyperoxic exposure involves signaling through nitric oxide and mitogen activated protein kinases  
256
Myocardial protection for acquired heart disease surgery: Results of a national survey
257
Myocardial protection for coronary bypass grafting: The Toronto Hospital perspective
258
Myocardial protection for neonatal cardiac surgery-the developmental status and ischemic damage in human heart cell
259
Myocardial protection in the immature heart
260
Myocardial Protection of Contractile Function After Global Ischemia by Physiologic Estrogen Replacement in the Ovariectomized Rat
261
Myocardial protection of the failing heart
262
Myocardial protection using diadenosine tetraphosphate with pharmacological preconditioning
263
Myocardial protection with endogenous overexpression of manganese superoxide dismutase
264
Myocardial protection with intermittent cold blood during aortic valve operation: antegrade versus retrograde delivery
265
Myocardial protection with intermittent cross-clamp fibrillation: Improvement with sodium-hydrogen exchange inhibition
266
Myocardial protection with pinacidil cardioplegia in the blood-perfused heart
267
Myocardial protection with postconditioning is not enhanced by ischemic preconditioning
268
Myocardial protection with potassium-channel openers is as effective as St. Thomasʹ solution in the rabbit heart
269
Myocardial protection with Sevoflurane in Coronary Artery Bypass Grafting Surgery
270
Myocardial Protection with Simultaneous Antegrade/Vein Graft Cardioplegia Compared to Antegrade Cardioplegia Alone in Elective Coronary Artery Bypass Grafting Patients
271
MYOCARDIAL PROTECTION: A CLINICAL COMPARISON OF COLD BLOOD CARDIOPLEGIA AND COLD CRYSTALLOID CARDIOPLEGIA
272
Myocardial protection: Efficacy of RS-C (Aqix®), a novel magnesium-cardioplegia, compared to St Thomasʹ hospital solution
273
Myocardial protection: Modern studies
274
MYOCARDIAL PROTECTION: NEW STRATEGIES FOR PREVENTING LETHAL REFERFUSION INJURY
275
Myocardial protective efficacy of lidocaine (with or without adenosine) as agents to induce polarised cardioplegic arrest during global ischaemia in rat hearts
276
Myocardial recovery after mechanical support for acute myocarditis: is sustained recovery predictable?
277
Myocardial Recovery and the Failing Heart: Myth, Magic, or Molecular Target?
278
Myocardial Redox State Predicts In-Hospital Clinical Outcome After Cardiac Surgery: Effects of Short-Term Pre-Operative Statin Treatment
279
Myocardial regeneration by endogenous adult progenitor cells
280
Myocardial regeneration by human amniotic fluid stem cells: Challenges to be overcome
281
Myocardial Regeneration by Stem Cells: Seeing the Unseeable
282
Myocardial regeneration with bone-marrow-derived stem cells
283
Myocardial regeneration: Roles of stem cells and hydrogels
284
Myocardial Regenerative Therapy: Immunologic Basis for the Potential “Universal Donor Cells”
285
Myocardial remodeling differs between LV and RV myocardium from patients with idiopathic-dilated myocarditis, end-stage heart failure  
286
Myocardial Remodeling Is Controlled by Myocyte-Targeted Gene Regulation of Phosphodiesterase Type 5
287
Myocardial remodelling in a mouse model of diabetic cardiomyopathy
288
Myocardial response to ischemic preconditioning: is it a novel predictor of prognosis?
289
Myocardial revascularisation after acute myocardial infarction
290
Myocardial revascularisation by laser
291
Myocardial revascularisation: the search for the Holy Grail
292
Myocardial revascularization
293
Myocardial revascularization for acute myocardial infarction: benefits and drawbacks of avoiding cardiopulmonary bypass
294
Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: Functional Observations
295
Myocardial revascularization in the elderly using beating heart coronary artery bypass surgery
296
Myocardial revascularization with and without cardiopulmonary bypass in multivessel disease: impact of strategy on midterm outcome
297
Myocardial revascularization with and without cardiopulmonary bypass in multivessel disease: impact of the strategy on early outcome
298
Myocardial revascularization with multiple arterial grafts: comparison between the radial artery and the right internal thoracic artery
299
Myocardial revascularization with radial and mammary arteries: initial and mid-term results
300
Myocardial revascularization with the left internal thoracic artery graft configuration
301
Myocardial revascularization with the posterior tibial artery
302
Myocardial revascularization with the radial artery: a clinical and angiographic study
303
Myocardial rupture after myocardial infarction is related to the perfusion status of the infarct-related coronary artery
304
Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial
305
Myocardial salvage by the use of reperfusion and intraaortic balloon pump: Experimental study
306
Myocardial salvage in patients with non–ST-elevation myocardial infarction determined by myocardial perfusion imaging
307
Myocardial Salvage Index and Infarct Size Represent Related But Distinct Components of Acute ST-Segment Elevation Myocardial Infarction
308
Myocardial Scar Detected by Cardiovascular Magnetic Resonance in a Competitive Bodybuilder With Longstanding Abuse of Anabolic Steroids
309
Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy
310
Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy
311
Myocardial Scars More Frequent Than Expected: Magnetic Resonance Imaging Detects Potential Risk Group Original Research Article
312
Myocardial scintigraphic study with 123I 15-(p-iodophenyl)-3(R,S)-methylpentadecanoic acid in patients with hypertrophic cardiomyopathy
313
Myocardial scintigraphy in a patient with transient mid-ventricular ballooning cardiomyopathy: Case report
314
Myocardial scintigraphy in acute myocardial infarction treated with systemic thrombolysis: how far are we from obtaining reliable information for rescue PTCA?
315
Myocardial self-preservative effect of heat shock protein 70 on an immature lamb heart
316
Myocardial Steatosis Is an Independent Predictor of Diastolic Dysfunction in Type 2 Diabetes Mellitus Original Research Article
317
Myocardial Strain and Strain Rate Imaging: Comparison between Doppler Derived Strain Imaging and Speckle Tracking Echocardiography
318
Myocardial Strain and Torsion Quantified by Cardiovascular Magnetic Resonance Tissue Tagging: Studies in Normal and Impaired Left Ventricular Function Review Article
319
Myocardial strain changes in Duchenne muscular dystrophy without overt cardiomyopathy
320
Myocardial strain rate is a superior method for evaluation of left ventricular subendocardial function compared with tissue Doppler imaging
321
Myocardial strain: can we finally measure contractility?
322
Myocardial Structural Effects of Aldosterone Receptor Antagonism in Heart Failure
323
Myocardial stunning after cerebral infarction
324
Myocardial stunning after off-pump coronary artery bypass grafting: safeguards and pitfalls
325
Myocardial stunning after off-pump coronary artery bypass grafting: safeguards and pitfalls: Reply
326
Myocardial stunning associated with a myocardial bridge
327
Myocardial stunning in hypertrophic cardiomyopathy with normal coronary arteries
328
Myocardial Substrate Oxidation During Warm Continuous Blood Cardioplegia
329
Myocardial sympathetic denervation prevents chamber-specific alteration of beta-adrenergic transmembrane signaling in rabbits with heart failure
330
Myocardial sympathetic innervation in patients with impaired glucose tolerance: relationship to subclinical inflammation
331
Myocardial Systolic Strain is Decreased After Aortic Valve Replacement in Patients With Aortic Insufficiency
332
Myocardial tactile stiffness during acute reduction of coronary blood flow
333
Myocardial Tactile Stiffness: Variable of Regional Myocardial Function
334
Myocardial Technetium-99m-Tetrofosmin Single-Photon Emission Computed Tomography Compared With 18F-Fluorodeoxyglucose Imaging to Assess Myocardial Viability
335
Myocardial Thievery: The Coronary-Subclavian Steal Syndrome
336
Myocardial time intervals preceding left ventricular filling in chronic coronary artery disease: value of a decreased septal ejection time
337
Myocardial tissue Doppler and long axis function in the fetal heart
338
Myocardial Tissue Doppler-Based Indexes to Distinguish Right Ventricular Volume Overload from Right Ventricular Pressure Overload
339
Myocardial tissue troponins T and I: An immunohistochemical study in experimental models of myocardial ischemia
340
Myocardial tissue velocity reduction is correlated with clinical neurologic severity in myotonic dystrophy
341
Myocardial toxoplasmosis complicating cardiac transplant
342
Myocardial transversely isotropic material parameter estimation from in-silico measurements based on a reduced-order unscented Kalman filter
343
Myocardial tumor necrosis factor–α expression does not correlate with clinical indices of heart failure in patients on left ventricular assist device support
344
Myocardial vacuolization, a marker of ischemic injury, in surveillance cardiac biopsies posttransplant: Correlations with morphologic vascular disease and endothelial dysfunction
345
MYOCARDIAL VASCULAR DYSFUNCTION FOLLOWING HEART SURGERY: IS ENOS ACTIVATION INVOLVED?
346
Myocardial velocity gradient as new indicator of regional left ventricular contraction: Detection by two-dimensional tissue doppler imaging technique
347
Myocardial velocity gradient as a noninvasively determined index of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy
348
Myocardial ventricular mass related to coronary artery distribution in human hearts
349
Myocardial viability and prognosis in patients with ischemic left ventricular dysfunction
350
Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial
351
Myocardial viability assessed by Dobutamine echocardiography in acute myocardial infarction after successful primary coronary angioplasty
352
Myocardial viability assessed by positron emission tomography in infants and children after the arterial switch operation and suspected infarction  
353
Myocardial Viability Assessment by Cardiac MRI in Cases of Pediatric Cardiomyopathy
354
Myocardial viability assessment by contrast-enhanced magnetic resonance imaging
355
Myocardial viability assessment by endocardial electroanatomic mapping: comparison with metabolic imaging and functional recovery after coronary revascularization
356
Myocardial Viability Assessment: Comparison between Resting Two Dimensional Visual Assessment of Dobutamine Stress Echocardiography and Strain Rate Imaging
357
Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction
358
Myocardial Viability Imaging: Dead or Alive?
359
Myocardial viability in patients with chronic coronary artery disease and previous myocardial infarction: Comparison of myocardial contrast echocardiography and myocardial perfusion scintigraphy
360
Myocardial viability inchronic ischemic heart disease: Comparison of contrast-enhanced magnetic resonance imaging with 18F-fluorodeoxyglucose positron emission tomography
361
Myocardial Viability Mapping by Magnetic Resonance-Based Multiparametric Systolic Strain Analysis
362
Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure
363
Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis
364
Myocardial viability: Contractile reserve or cell membrane integrity?
365
Myocardial viability: Methods of assessment and clinical relevance
366
Myocardial Wall Thickness and Left Ventricular Geometry in Hypertensives: Relationship With Insulin
367
Myocardial wall thickness predicts recovery of contractile function after primary coronary intervention for acute myocardial infarction Original Research Article
368
Myocardial wall velocity assessment by pulsed Doppler tissue imaging: Characteristic findings in normal subjects
369
Myocardial-Directed Overexpression of the Human β1-Adrenergic Receptor in Transgenic Mice
370
Myocardial-Infraction Based on Intelligent Techniques
371
Myocardial-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block
372
Myocardialβ-adrenergic and Muscarinic Receptor Density in Cardiac Pressure or Volume Overload
373
Myocardin and smooth muscle differentiation
374
Myocardin: A Component of a Molecular Switch for Smooth Muscle Differentiation
375
Myocardiocyte apoptosis in heart failure in chronic Chagasʹ disease
376
Myocarditis and cardiomyopathy associated with clozapine
377
Myocarditis and idiopathic dilated cardiomyopathy
378
Myocarditis and long-term survival in peripartum cardiomyopathy
379
Myocarditis and Meningitis during Early Sepsis in a Neonate with Streptococcus pseudopneumoniae: A Case Report
380
Myocarditis and primary Sjögrenʹs syndrome
381
Myocarditis and primary Sjogrenʹs syndrome Original Research Article
382
Myocarditis and subcutaneous granulomas in a patient with Crohnʹs disease of the colon
383
Myocarditis associated with 2009 influenza A (H1N1) virus in children
384
Myocarditis associated with immune checkpoint inhibitors: Practical considerations in diagnosis and management
385
Myocarditis Complicating Pregnancy in Dengue Hemorrhagic Fever- A Case Report
386
Myocarditis Diagnosed in Twins
387
Myocarditis due to Salmonella virchow and sudden infant death
388
Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms
389
Myocarditis in systemic lupus erythematosus
390
Myocarditis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy
391
Myocarditis with ST-Elevation Myocardial Infarction presentation in young man. A case series of 11 patients
392
Myocarditis, a Life-Threatening Presentation of COVID-19 in a 4-Month-Old Infant
393
Myocarditis, Pericarditis, and Cardiac Tamponade Associated With Rocky Mountain Spotted Fever
394
Myocarditis: the unexpected return of smallpox vaccine adverse events
395
Myocardium proteome remodelling after nutritional deprivation of methyl donors
396
Myocardium-targeted delivery of endothelial progenitor cells by ultrasound-mediated microbubble destruction improves cardiac function via an angiogenic response
397
Myocilin Mutations Are Not a Major Cause of Primary Congenital Glaucoma in Iranian Patients
398
Myoclonic encephalopathy after exposure to aluminium
399
Myoclonic encephalopathy in the CDKL5 gene mutation
400
Myoclonic epilepsy masquerading as a tic disorder
401
Myoclonic seizures combined with partial seizures and probable pathophysiology of secondary bilateral synchrony
402
Myoclonic status epilepticus following high-dosage lamotrigine therapy
403
Myoclonic–astatic epilepsy of early childhood – clinical and EEG analysis of myoclonic–astatic seizures, and discussions on the nosology of the syndrome
404
Myoclonus associated with etomidate for ED procedural sedation and analgesia
405
Myoclonus, Seizure, and Ventricular Fibrillation after Intrathecal Injection of Tranexamic Acid
406
Myoclonus: current concepts and recent advances
407
Myocutaneous Mucormycosis in a Diabetic Burnt Patient Led to Upper Extremity Amputation; A Case Report
408
Myocyte Apoptosis and Reduced SR Gene Expression Precede the Transition from Chronically Stunned to Hibernating Myocardium
409
Myocyte apoptosis: programming ventricular remodeling
410
Myocyte contractility with caspase inhibition and simulated hyperkalemic cardioplegic arrest
411
Myocyte damage in myopathic cell model
412
Myocyte degeneration and cell death in hibernating human myocardium
413
Myocyte diameter and fractional area of collagen are not associated with survival time of outpatients with idiopathic dilated cardiomyopathy: A study based on right ventricular endomyocardial biopsies
414
Myocyte electrophysiological properties following the development of supraventricular tachycardia-induced cardiomyopathy
415
Myocyte Growth and Cardiac Repair
416
Myocyte nuclear area as a measure of left ventricular hypertrophy in transplant patients
417
Myocyte production of nitric oxide in response to AChR-reactive antibodies in two inbred rat strains may influence disease outcome in experimental myasthenia gravis
418
Myocyte transplantation for myocardial repair: a few good cells can mend a broken heart
419
Myocytes die by multiple mechanisms
420
Myocytes Isolated from Rejecting Transplanted Rat Hearts Exhibit a Nitric Oxide-mediated Reduction in the Calcium Current
421
Myocytes Isolated From Rejecting Transplanted Rat Hearts Exhibit Reduced Basal Shortening Which is Reversible by Aminoguanidine
422
Myocytes Respond to both Interleukin-4 and Interferon-γ: Cytokine Responsiveness with the Potential to Influence the Severity and Course of Experimental Myasthenia Gravis
423
Myoelectric Activity of Individual Lumbar Erector Spinae Muscles Variation by Differing Seat Pan Depth
424
Myoelectric manifestations of sternocleidomastoid and anterior scalene muscle fatigue in chronic neck pain patients
425
MYOELECTRIC RESPONSE OF BACK MUSCLES TO VERTICAL RANDOM WHOLE-BODY VIBRATION WITH DIFFERENT MAGNITUDES AT DIFFERENT POSTURES
426
Myoelectric signal compression using zero-trees of wavelet coefficients
427
Myoendometrial versus placental uterine arteries: Structural, mechanical, and functional differences in late-pregnant rabbits
428
Myoepithelial cell cocktail (p63+SMA) for the evaluation of sclerosing breast lesions
429
Myoepithelioma metatatic to the orbit
430
Myoepithelioma of the breast
431
Myofascial Pain and Dysfunction: The Trigger Point Manual, Vol 1: Upper Half of Body (2nd Ed.): Authors: Simons, Travell and Simons; Publisher: Williams and Wilkins, 1999; Pages: 1038 pp
432
Myofascial Pain Dysfunction Syndrome (MPDS)
433
Myofascial pain syndromes and their evaluation
434
Myofiber angle distributions in the ovine left ventricle do not conform to computationally optimized predictions
435
Myofiberbreak-up: A marker of ventricular fibrillation in sudden cardiac death
436
Myofibrillar 1-D fingerprints and myosin heavy chain MS analyses of beef loin at 36 h postmortem correlate with tenderness at 7 days
437
Myofibrillar protein extracts from spent hen meat to improve whole muscle processed meats
438
Myofibrillar protein oxidation induced by post-ischemic reperfusion in isolated rat hearts
439
Myofibrillar protein profile of Pectoralis major muscle in broiler chickens subjected to different freezing and thawing methods
440
Myofibrillar troponin C Ca binding kinetics in heart cells at rest are like soluble troponin C kinetics
441
Myofibrillar Troponin Exists in Three States and there Is Signal Transduction along Skeletal Myofibrillar Thin Filaments
442
Myofibroblastic Sarcoma in the Limb of a Horse
443
Myofibroblastoma and solitary fibrous tumour of the breast: histopathologic and immunohistochemical studies
444
Myofibroblastoma of the Breast: A Morphologic and Immunohistochemical Study of Three Cases
445
Myofibroblastoma of the Breast: Literature Review andCase Report
446
Myofibroblasts and hepatocellular carcinoma: an in vivo and in vitro study
447
Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study
448
Myofibroblasts in Calcifying Odontogenic Cyst and Dentigerous Cyst
449
Myofibroblasts in the cirrhotic rat liver reflect hepatic remodeling and correlate with fibrosis and sinusoidal capillarization
450
Myofibroblasts overexpress osteonectin in hepatocellular carcinoma (HCC)
451
Myofibroma as a Rapidly Growing Gingival Mass in a 4-year-old Boy: a Case Report
452
Myofilament and cytoskeleton proteins: Fine machineries of biological movements
453
Myofilament incorporation and contractile function after gene transfer of cardiac troponin I Ser43/45Ala
454
Myofilament incorporation determines the stoichiometry of troponin I in transgenic expression and the rescue of a null mutation
455
Myogenesis in sheep is altered by maternal feed intake during the peri-conception period
456
Myogenic and flow-mediated responses in isolated mesenteric small arteries from pregnant and nonpregnant rats
457
Myogenic Differentiation Potential of Human Newborn Foreskin Stem Cells Combined with Polycaprolactone-Based Nanofiber
458
Myogenic Endothelial Cells Purified From Human Skeletal Muscle Improve Cardiac Function After Transplantation Into Infarcted Myocardium Original Research Article
459
Myogenic nature of insect heartbeat and intestinal peristalsis, revealed by neuromuscular paralysis caused by the sting of a braconid wasp
460
Myogenic reactivity is enhanced in rat radial uterine arteries in a model of maternal undernutrition
461
Myogenic signaling by lithium in cardiomyoblasts is Akt independent but requires activation of the β-catenin-Tcf/Lef pathway
462
Myogenin and Class II HDACs Control Neurogenic Muscle Atrophy by Inducing E3 Ubiquitin Ligases
463
Myogenous Temporomandibular Disorders: Diagnostic and Management Considerations
464
Myoglobin (MYO) and cardiac troponin I (CTNI) in diagnosis of suspected acute myocardial infarct (AMI)-Myoglobin (MYO) and cardiac troponin I (CTNI) in diagnosis of suspected acute myocardial infarct (AMI)
465
Myoglobin adsorption onto poly(glycidyl methacrylate) microbeads with surface functionalized iminodiacetic acid
466
Myoglobin and haemoglobin-mediated lipid oxidation in washed muscle: Observations on crosslinking, ferryl formation, porphyrin degradation, and haemin loss rate
467
Myoglobin and lipid oxidation interactions: Mechanistic bases and control
468
Myoglobin as a model system for designing heme protein based blood substitutes Original Research Article
469
Myoglobin as marker in meat adulteration: A UPLC method for determining the presence of pork meat in raw beef burger
470
Myoglobin dynamics: evidence for a hybrid solid/fluid state of matter
471
Myoglobin Expression in Chelonia mydas Brain, Heart and Liver Tissues
472
Myoglobin immobilization on electrodeposited nanometer-scale nickel oxide particles and direct voltammetry Original Research Article
473
Myoglobin immobilized on LaF3 doped CeO2 and ionic liquid composite film for nitrite biosensor
474
Myoglobin in polyacrylamide hydrogel films: direct electrochemistry and electrochemical catalysis
475
Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: A Thrombolysis in Myocardial Infarction 10B substudy
476
Myoglobin modified electrodes as anchors for d metal cationic complexes
477
Myoglobin within graphene oxide sheets and Nafion composite films as highly sensitive biosensor
478
Myoglobin, creatine kinase MB isoforms and creatine kinase MB mass in early diagnosis of myocardial infarction in patients with acute chest pain
479
Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: Results from TIMI 10A, , , ,
480
Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction : Results from the thrombolysis in myocardial infarction study (TIMI) 10B
481
Myoglobin/arylhydroxylamine film modified electrode: Direct electrochemistry and electrochemical catalysis
482
Myoglobin-Catalyzed bis-Allylic Hydroxylation and Epoxidation of Linoleic Acid
483
Myoglobin-Induced Oxidative Damage: Evidence for Radical Transfer from Oxidized Myoglobin to Other Proteins and Antioxidants
484
Myoid Angioendothelioma of the Spleen: A Rare Case Report and Literature Review
485
Myoid hamartoma of breast with chondroid metaplasia: a casereport
486
Myo-inositol 1,4,6-trisphosphorothioate and myo-inositol 1,3,4-trisphosphorothioate: New synthetic Ca2+-mobilising partial agonists at the inositol 1,4,5-trisphosphate receptor
487
myo-Inositol 4,6-carbonate: an easily prepared small molecule with three syn-axial hydroxyl groups
488
Myo-inositol at High Concentration Reduced Viability and Proliferation of Rat Bone Marrow Mesenchymal Stem Cells via Electrolyte Imbalance and Elevation of Aerobic Metabolism
489
Myo-inositol catabolism by Rhizobium in soil: HPLC and enzymatic studies
490
Myo-inositol catabolism by Rhizobium in soil: HPLC and enzymatic studies
491
Myo-inositol effect on pregnancy outcomes in infertile women undergoing in vitro fertilization/intracytoplasmic sperm injection: A double-blind RCT
492
myo-Inositol esters of indomethacin as COX-2 inhibitors Original Research Article
493
Myo-inositol hexakisphosphate degradation by Bifidobacterium infantis ATCC 15697
494
Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 tesla
495
myo-Inositol Monophosphatase from Rat Testes: Purification and Properties
496
Myo-Inositol Monophosphatase: Binding of Terbium and a Cross-Linking Reagent to the Catalytic Site Cavity
497
myo-Inositol Oxygenase Offers a Possible Entry Point into Plant Ascorbate Biosynthesis
498
Myoiti aociated with a Baerveldt glaucoma implant
499
Myokymia and neuromyotonia in 37 Jack Russell terriers
500
Myokymia and neuromyotonia in veterinary medicine: A comparison with peripheral nerve hyperexcitability syndrome in humans
501
Myoma expulsion after uterine artery embolization: Complication or cure?
502
Myomectomy fever: testing the dogma
503
Myomesin 3, a Novel Structural Component of the M-band in Striated Muscle
504
Myomesin is a Molecular Spring with Adaptable Elasticity
505
Myometrial Apoptosis: Activation of the Caspase Cascade in the Pregnant Rat Myometrium at Midgestation
506
Myometrial arginase activity increases with advancing pregnancy in the guinea pig, , ,
507
Myometrial contractile strain at uteroplacental separation during parturition
508
Myometrial function in prematurity
509
Myometrial hyperplasia in pediatric, adolescent, and young adult uteri
510
Myometrial LH/hCG receptors during the estrous cycle and pregnancy in pigs
511
Myometrial nitric oxide synthase messenger ribonucleic acid expression does not change throughout gestation or with the onset of labor,
512
Myometrial thickness during human labor and immediately post partum
513
Myonecrosis After Revascularization Procedures
514
Myopathic involvement in two cases of Hallervorden-Spatz disease
515
Myopathy in acquired partial lipodystrophy
516
Myopathy resulted from the excessive long administration of Traimecinolone
517
Myopathy, Statins, and Vitamin D Deficiency
518
Myopathy-dependent changes in activity of ATPase, SDH and GPDH and NOS expression in the different fibre types of hamster muscles
519
Myopericarditis: Etiology, management, and prognosis
520
Myopia and Inflammation
521
Myopia and its mechanisms
522
Myopia and Regional Variations in Retinal Thickness in Healthy Eyes
523
Myopia and viion 2020
524
Myopia Control: A Citation Network Study
525
Myopia in Adult with Retinopathy of Prematurity Original Reearch Article
526
Myopia Progression in Low Birth Weight Infants: A Narrative Review
527
Myopia, liquidity constraints, and aggregate consumption: what do the data say?
528
Myopia, redistribution and pensions
529
Myopic and perfect foresight in the OLG model
530
Myopic atigmatim and prebyopia
531
Myopic atigmatim and prebyopia trial
532
Myopic atigmatim: abtract v article
533
Myopic biases in competitions
534
Myopic loss aversion, disappointment aversion, and the equity premium puzzle
535
Myopic loss aversion: Information feedback vs. investment flexibility
536
Myopic prediction, self-destructive secrecy, and the unexpected benefits of revealing final deadlines in negotiation
537
Myopic prospect theory vs. myopic loss aversion: how general is the phenomenon?
538
Myopic random walkers and exclusion processes: Single and multispecies
539
Myopic Regreion After Laer In itu Keratomileui: A Medical Alternative to urgical Enhancement
540
Myopic Social Prediction and the Solo Comparison Effect
541
Myopic trabimu fixu: a mitochondrial myopathy?
542
Myoplasmic Ca2+ concentration during exertional rhabdomyolysis
543
MyoRing Implantation in Keratoconic Patients: 3 years Follow-up Data
544
MyoRing Implantation with and without Corneal Collagen Crosslinking for the Management of Keratoconus
545
Myosin and kinesin: mother and child reunited
546
Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy Original Research Article
547
Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle
548
Myosin Binding Protein C Positioned to Play a Key Role in Regulation of Muscle Contraction: Structure and Interactions of Domain C1
549
Myosin binding protein-C: structural and functional complexity
550
Myosin Binding Surface on Actin Probed by Hydroxyl Radical Footprinting and Site-Directed Labels
551
Myosin cross-bridge mechanics: geometrical determinants for continuous sliding
552
Myosin dynamics on the millisecond time scale Original Research Article
553
Myosin expression in the jaw-closing muscles of the domestic cat and american opossum
554
Myosin filament depolymerizes in a low ionic strength solution containing l-histidine
555
Myosin from failing and non-failing human ventricles exhibit similar contractile properties
556
Myosin head mechanical performance under different conformational change mechanisms
557
Myosin Heads in Solution: How to Interpret the Data Obtained by Means of X-Ray and Neutron Scattering?
558
Myosin heavy chain and fibre diameter of extrinsic tongue muscles in rhesus monkey
559
Myosin heavy chain B isoform is more predominant in rat veins than arteries
560
Myosin heavy chain degradation during post mortem storage of Atlantic cod (Gadus morhua L.)
561
Myosin heavy chain fibre types and fibre sizes in nuliparous and primiparous ovariectomized Iberian sows: Interaction with two alternative rearing systems during the fattening period
562
Myosin heavy chain isoform composition influences the susceptibility of actin-activated S1 ATPase and myofibrillar ATPase to pH inactivation
563
Myosin heavy chain isoform immunolabelling in diabetic rats with peripheral neuropathy
564
Myosin heavy chain isoforms account for variation in pork quality
565
Myosin heavy chain isoforms expressed in bovine skeletal muscles
566
Myosin heavy chain isoforms influence myofibrillar ATPase activity under simulated postmortem pH, calcium, and temperature conditions
567
Myosin heavy chain profiles and body composition are different in old versus young Standardbred mares
568
Myosin II is important for maintaining regulated secretion and asymmetric localization of chitinase 1 in the budding yeast Saccharomyces cerevisiae
569
Myosin II-Dependent Cortical Movement Is Required for Centrosome Separation and Positioning during Mitotic Spindle Assembly
570
Myosin is solubilized in a neutral and low ionic strength solution containing l-histidine
571
Myosin Isoform Determines the Conformational Dynamics and Cooperativity of Actin Filaments in the Strongly Bound Actomyosin Complex
572
Myosin Learns to Recruit AMPA Receptors
573
Myosin light chain 1 release from myofibrillar fraction during postmortem aging is a potential indicator of proteolysis and tenderness of beef
574
Myosin Light Chain Gene Expression Associated with Disease States of the Human Heart
575
Myosin light chain I grade: A simple marker for the severity and prognosis of patients with acute myocardial infarction, , ,
576
Myosin light chain kinase and pulmonary responses after acute ethanol exposure and burn injury
577
Myosin light chain kinase and the role of myosin light chain phosphorylation in skeletal muscle
578
Myosin light chain kinases and phosphatase in mitosis and cytokinesis
579
Myosin Light Chain Phosphorylation in Cardiac Hypertrophy and Failure due to Myocardial Infarction
580
Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2
581
Myosin Mechanochemistry
582
Myosin phosphatase isoform switching in vascular smooth muscle development
583
Myosin Vb Mobilizes Recycling Endosomes and AMPA Receptors for Postsynaptic Plasticity
584
Myosin VI Rewrites the Rules for Myosin Motors
585
Myosin VI Undergoes Cargo-Mediated Dimerization
586
Myosins and DYNLL1/LC8 in the honey bee (Apis mellifera L.) brain
587
Myosins Are Motor Proteins of the Actomyosin Motility System: Association with Membranes and with the Signal Pathways
588
Myositis Ossificans Circumscripta of the Supra-orbital Region: A Case Report
589
MYOSITIS OSSIFICANS OF HAND
590
Myositis ossificans of the chest wall simulating malignant neoplasm
591
Myositis ossificans of the medial pterygoid muscles: A case report
592
Myositis Ossificans Progressiva in the Whole Spine: A Case Report
593
Myositis ossificans traumatica of the temporal muscle: a case report
594
Myosplint decreases wall stress without depressing function in the failing heart: a finite element model study
595
Myospryn associates to desmin and is important in heart development
596
Myostatin Dominant Negative Allele Products Interact Positively with Wild Type Monomers
597
Myostatin expression is not altered by insulin deficiency and replacement in streptozotocin-diabetic rat skeletal muscles
598
Myostatin gene knockdown through lentiviral-mediated delivery of shRNA for in vitro production of transgenic bovine embryos
599
Myostatin Gene Polymorphism and Its Association with Production Traits in Western Azerbaijan Native Chickens
600
Myostatin gene targeting in cultured China Han ovine myoblast cells
601
Myosteatosis and myofibrosis: Relationship with aging, inflammation and insulin resistance
602
Myostimulatory neuropeptides in cockroaches: structures, distribution, pharmacological activities, and mimetic analogs
603
Myotendinous lengthening of the elbow flexor muscles to improve active motion in patients with elbow spasticity following brain injury
604
Myotilinopathy – A report on four UK patients
605
Myotomy through heart-port access for myocardial bridging
606
Myotonic disorders: A review article
607
Myotonic Dystrophy Confirmed after Cesarean Section
608
Myotonic dystrophy gene identified
609
Myotonic dystrophy is a significant cause of idiopathic polyhydramnios, ,
610
Myotonic Dystrophy Protein Kinase (DMPK) Gene Expression in Lymphocytes of Patients with Myotonic Dystrophy
611
Myotopography in Tibial Lengthening
612
Myotoxic Effects of Atorvastatin Drug (Lipitor) on the Skeletal Muscles of Adult Male Albino Rats and the Effect of L- Carnitine Co-administration Light Microscopical, Immunohistochemical and Biochemical Study
613
Myotoxicity of bupivacaine versus levobupivacaine: histological study in adult albino rats
614
Myotrophin in human heart failure
615
Myotropic effect of helicokinins, tachykinin-related peptides and Manduca sexta allatotropin on the gut of Heliothis virescens (Lepidoptera: Noctuidae)
616
Myrcene Consumption and Restrain Stress: An In Vivo Comparative Study on an Alzheimer’s Disease Model and In Vitro Investigation on Abeta Fibrils
617
Myrciaine, a new nicotinic ester from Myrcia blanchetiana (Myrtaceae)
618
Myriad loses rights to breast cancer gene patent
619
Myriad molecules drive nervous-system development
620
Myriad-Type Polynomial Filtering
621
Myriastramides A–C, new modified cyclic peptides from the Philippines marine sponge Myriastra clavosa
622
MyRice: Pangkalan Data Pengetahuan Padi Malaysia
623
Myricetin affords protection against peroxynitrite-mediated DNA damage and hydroxyl radical formation
624
Myricetin can mitigate altered redox status in type 2 diabetic erythrocytes
625
Myricetin directly targets JAK1 to inhibit cell transformation
626
Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathway
627
Myricetin inhibits Escherichia coli DnaB helicase but not primase Original Research Article
628
Myricetin sensitizes malignant glioma cells to TRAIL-mediated apoptosis by down-regulation of the short isoform of FLIP and bcl-2
629
Myricetin stimulates the absorption of the pro-carcinogen PhIP
630
Myricetin suppresses LPS-induced MMP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKL-induced RAW 264.7 cells
631
Myricitrin as a substrate and inhibitor of myeloperoxidase: Implications for the pharmacological effects of flavonoids
632
Myricitrin protects against peroxynitrite-mediated DNA damage and cytotoxicity in astrocytes
633
MYRINGOPLASTY IN SIMPLE CHRONIC OTITIS MEDIA
634
MYRINGOPLASTY, ONLAY VERSUS UNDERLAY TECHNIQUE
635
Myringoplasty: A Comparative Study of Different Graft Materials and Various Surgical Techniques
636
Myringoplasty: A Comparison of Bismuth Iodoform Paraffin Paste Gauze Pack and Plane Gauze (containing Lococotien with Veoform)
637
Myringotomy with versus without grommet tube insertion in chronic serous otitis media with effusion : Southern Oman experience
638
Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity
639
Myriocin, an inhibitor of serine palmitoyl transferase, impairs the uptake of transferrin and low-density lipoprotein in mammalian cells
640
Myrionecta rubra (Mesodinium rubrum) bloom initiation in the Columbia River estuary
641
Myrioneurinol: a novel alkaloid skeleton from Myrioneuron nutans
642
Myriophyllum alterniflorum DC. Effect of low concentrations of copper and cadmium on somatic and photosynthetic endpoints: A chemometric approach
643
Myriophyllum alterniflorum DC., biomonitor of metal pollution and water quality. Sorption/accumulation capacities and photosynthetic pigments composition changes after copper and cadmium exposure
644
Myriophyllum aquaticum as a biomonitor of water heavy metal input related to agricultural activities in the Xanaes River (Cَrdoba, Argentina)
645
Myriophyllum spicatum-released allelopathic polyphenols inhibiting growth of blue-green algae Microcystis aeruginosa
646
MYRISTATE BINDING TO ENDOTHELIAL LOCALIZED CD36 MEDIATES THE ACTIVATION OF NITRIC OXIDE SYNTHASE
647
Myristic acid, unlike palmitic acid, is rapidly metabolized in cultured rat hepatocytes
648
Myristic acid/polyaniline composites as form stable phase change materials for thermal energy storage
649
Myristica Fragrans Houtt Extract Attenuates Neuronal Loss and Glial Activation in Pentylenetetrazol-Induced Kindling Model
650
Myristoylated Alanine Rich C Kinase Substrate (MARCKS) is essential to β2-integrin dependent responses of equine neutrophils
651
Myristoylated Alanine Rich C Kinase Substrate (MARCKS) is essential to β2-integrin dependent responses of equine neutrophils
652
Myristoylated Alanine-Rich protein Kinase C Substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo
653
Myristoylation Cannot Functionally Replace the Isoprenylation of Rab5
654
Myristoylation of Protein at a Distinct Position Allows Its Phosphorylation by Protein Kinase C
655
Myristoylation-regulated Direct Interaction Between Calcium-bound Calmodulin and N-terminal Region of pp60v-src
656
Myrmecochory and short-term seed fate in Rhamnus alaternus: Ant species and seed characteristics
657
Myrmecochory by small ants – Beneficial effects through elaiosome nutrition and seed dispersal
658
Myron Prinzmetal 1908–1987: The man behind the variant angina
659
Myrosinase-generated isothiocyanate from glucosinolates: Isolation, characterization and in vitro antiproliferative studies Original Research Article
660
Myrrh a traditional medicine or a multipurpose pharmaceutical excipient
661
MYRRHA – A multi-purpose fast spectrum research reactor
662
MYRRHA: A multipurpose accelerator driven system for research & development
663
MYRRHA: A multipurpose accelerator driven system for research & development
664
MYRRHA: A multipurpose accelerator driven system for research & development
665
Myrtaceae revisited: a reassessment of infrafamilial group
666
Myrtenol Protects Against Acute Kidney Injury Induced by Cisplatin in Mice
667
Myrtle Ashmole and Philip Ashmole: The Carrifran Wildwood Story. Published by The Borders Forest Trust (2009). 223 pp., Price £15, paperback, ISBN: 978-0-9534346-4-0. Only available from: The Borders Forest Trust, Ancrum, Jedburgh, Scotland, TD8 6TU. .
668
Myrtle Essential Oil-Loaded Alginate Nanoparticles: A Dual Therapeutic Approach for Cytotoxicity Against Skin Cancer Cells and Antibacterial Effects on Common Pathogens
669
Myrtle hydroalcoholic extracts obtained from different selections of Myrtus communis L.
670
Myrtle McGrawʹs Neurobehavioral Theory of Development,
671
Myrtle McGrawʹs Unrecognized Conceptual Contribution to Developmental Psychology,
672
Myrtus communis L. as source of a bioactive and safe essential oil
673
MYRVIN HAROLD ELLESTAD, MD: a conversation with the editor
674
MySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot study
675
MYSELF, SPLIT OPEN: OVID, RUKEYSER, AND THE TRAUMATIC POETICS OF ORPHIC RE-MEMBERING
676
Mysids and trace metals: disruption of swimming as a behavioural indicator of environmental contamination
677
Mysovskii-type theorem for the Secant method under Hölder continuous Fréchet derivative
678
MYSS: should we alter clinical practice?
679
MYSS: should we alter clinical practice?
680
Mysteries of medulloblastoma yield to genomic researchers
681
Mysteries of morality
682
Mysteries of Motor Mechanics
683
Mysteries of the arc cathode spot: A retrospective glance
684
Mysteries of the Transferrin-Transferrin Receptor 1 Interaction Uncovered
685
Mysteries Unraveled by Channels Gone Awry
686
Mysteries, marvels, and mayhem of space on the Web
687
Mysterious attendance cycles in Coryʹs shearwater, Calonectris diomedea: an exploration of patterns and hypotheses
688
Mysterious brain disease kills eagles, ducks and coots in Eastern USA
689
Mysterious circles in the Namib Desert: review of hypotheses on their origin
690
Mysterious deaths of aquatic reptiles, with special emphasis on the Indian Flap-shelled turtle Lissemys punctata (Bonnaterre, 1789) from Gujarat State, India
691
Mysterious diel cycles of mercury emission from soils held in the dark at constant temperature
692
Mysterious episodic coma
693
Mysterious falls and a nasal voice
694
Mysterious fat. The different impact of fat content on toddlers’ and adults’ food intake
695
Mysterious ground states in the organic conductor α-(BEDT-TTF)2KHg(SCN)4 : Mixed SDW and CDW?
696
Mysterious Linkages Between Hepatitis C Virus Genotypes, Interleukin-28B Genotypes and Viral Clearance- A Meta-Analysis
697
ʹMysteriousʹ moose disease in Sweden. Similarities to copper deficiency and/or molybdenosis in cattle and sheep. Biochemical background of clinical signs and organ lesions
698
Mysterious rectal bleeding in a female adolescent
699
Mystery and music from a talented medical student
700
Mystery at the museum
701
Mystery of Biphasic Defibrillation Waveform Efficacy: Is it Calcium?
702
Mystery of porous SnO2 thin film formation by pulsed delivery
703
Mystery of the Muse in Wallace Stevens The Idea of Order at Key West
704
Mystery of the rational iteration arising from relaxed Newton’s method
705
Mystery of the Silk Road
706
Mystery or Deviance: Sexology Discourse in Turkey Between 1930-60
707
Mystery pictures decoded
708
Mystery to mastery: the CSU Information Competence Project
709
Mystery, complexity, legibility and coherence: A meta-analysis
710
Mystical Analysis of Dream and its Effects in the Holy Quran
711
mystical analysis of the manifestation verse and its relationship with the spiritual journey
712
Mystical Chants in the Bajau Society: A Preliminary Observation on the Changes in the Mindset Towards the Planting Ritual
713
MYSTICAL ELEMENTS AND WORSHIP AMONG MALAY COMMUNITY IN PULAU BESAR, MELAKA
714
MYSTICAL POWERS OF WITCHCRAFT AMONG THE GBAGYIS
715
Mystification and social agent absences: a critical discourse analysis using evolutionary psychology
716
Myth and ceremony in workfare: rights, contracts, and client satisfaction
717
Myth and Media: Constructing Aboriginal Architecture
718
Myth and paradox of coronary risk and the menopause
719
Myth and Power
720
Myth and reality in the rain forest: how conservation strategies are failing West Africa By John F. Oates, 1999, University of California Press, 310 pp. ISBN 0-52022-252-0
721
Myth and reality of the hybrid desalination process Original Research Article
722
Myth and reality: A response to Lynn on the determinants of Italyʹs North–South imbalances
723
Myth and Science
724
Myth in the Holy Qur’an
725
Myth of market needs and technology seeds as a source of product innovation — an analysis of pharmaceutical new product development in an anti-hypertensive product innovation
726
Myth of symmetry: Public relations as cultural styles
727
Myth of the ideal cesarean section rate: Commentary and historic perspective
728
Myth of the menopause paradox
729
Myth or Reality: Self-Assessment Is Central to Effective Curriculum in Anatomical Pathology Graduate Medical Education
730
Myth or reality: The absence of evangelical Christian fiction titles in the public libraries of the United States
731
Myth or reality? Coexisting phonological disorders and stuttering
732
Myth, law and order: Schmitt and Benjamin read reflections on violence
733
Myth, magic, and the history of modern medicine
734
Myth, National Identity and Iranians Attitude towards International Relations
735
Myth, reality, and reform: higher education policy in Latin America: Claudio De Moura Castro and Daniel C. Levy; Inter-American Development Bank, Washington, D.C., 2000, pp. vi+116, price US $19.95 paperback
736
Myth-Centered Medicine in Ancient Greece and the Cognitive Effect Relationship between Medical Notions and Treatment Methods
737
Mythe, délire et psychiatrie. Essai dʹétude psychopathologique
738
Mythen detector system
739
Mythen detector system
740
MythenII: A 128 channel single photon counting readout chip
741
MythenII: A 128 channel single photon counting readout chip
742
Mythic Collaboration
743
Mythic Frodo and his Predestinate Call to Adventure
744
Mythological analysis of boating tourism
745
MYTHOLOGICAL ANALYSIS OF ỌJAADỊLỊ AND AKỤ FECHAA
746
MYTHOLOGICAL APPROACHES an‎d ARCHETYPES IN POST-9/11 HOLLYWOOD
747
Mythological Motifs in the Tauroctony Sculpture
748
Mythological Quests In Turkish Literature
749
Mythomania? Methods and morals from ‘The Myth of Language Universals’
750
Myths about cancer might interfere with screening decisions
751
Myths about later-day extensions of Darcyʹs law
752
Myths about spider envenomations and necrotic skin lesions
753
Myths About Surgical Myectomy: Rumors of Its Death Have Been Greatly Exaggerated
754
Myths about the treatment of addiction
755
Myths about workplace violence, harassment and bullying
756
Myths and facts about electricity in the U.S. South
757
Myths and legends as Malaysian tourism products: A case study of Lenggong Valley
758
Myths and misconceptions about student ratings of college faculty: Separating fact from fiction
759
Myths and Misconceptions of Wernicke’s Encephalopathy: What Every Emergency Physician Should Know
760
Myths and realities about the recovery of L׳Aquila after the earthquake
761
Myths and realities of academic labor markets
762
Myths and stereotypes of actors involved in domestic violence: Implications for domestic violence culpability attributions
763
Myths of Disaster Education: A Rebuttal
764
Myths of Electric Regulation: Looking at the Future of Energy through Entrepreneurial Eyes
765
Myths of skeptical environmentalism
766
Myths of slash and burn on physical degradation of savannah soils: impacts on Vertisols in north Cameroon
767
Myths regarding alternative fuel vehicle demand by light-duty vehicle fleets
768
Myths regarding exposure therapy for PTSD Original Research Article
769
Myths Regarding the NINDS rt-PA Stroke Trial: Setting the Record Straight
770
Myths, fables and even truths about warts and human papillomavirus
771
Myths, medicine, and meaning
772
Mytilopsis leucophaeata, an alien dreissenid bivalve discovered in the Gulf of Gdańsk (southern Baltic Sea)
773
Mytilus californianus as an indicator of heavy metals on the northwest coast of Baja California, Mexico
774
Mytilus galloprovincialis filter feeding on the bacterial community in a Mediterranean coastal area (Northern Ionian Sea, Italy
775
Mytilus galloprovincialis-type foot-protein-1 alleles occur at low frequency among mussels in the Dutch Wadden Sea
776
Myung-Gun Choo, The New Asia in Global Perspective
777
Myxedema psychosis with grade II hypothyroidism
778
Myxedema Psychosis: Neuropsychiatric Manifestations andRhabdomyolysis Unmasking Hypothyroidism
779
Myxing It Up to Study Chondramides
780
Myxobolus cerebralis (Myxozoa), the causative agent of whirling disease, reduces fecundity and feeding activity of Tubifex tubifex (Oligochaeta)
781
Myxobolus Spp. (Myxosporea: Myxobolidea) from fishes of the Zayandeh-rud River (Esfahan, Iran); new hosts and locality record.
782
Myxococcus xanthusʹ killed cells as inducers of struvite crystallization. Its possible role in the biomineralization processes
783
Myxofibrosarcoma of the Breast in a Young Pregnant Woman: A Case Report and Review of the Literature
784
Myxofibrosarcoma of the hypopharynx
785
Myxoglobulosis, A Rare Variant of Appendiceal Mucocele: Case Report and Review of the Literature
786
Myxoid Chondrosarcoma of Maxilla in a Pediatric Patient:A Rare Case Report
787
Myxoid liposarcoma: Sequences of the T(12; 16)(Q13; P11) from a primitive tumour
788
Myxoid Retroperitoneal Liposarcoma in a Patient with Personal and Family History of Different Cancers
789
Myxoid solitary fibrous tumour of the ischiorectal fossa
790
MYXOID VARIANT OF MALIGNANT FIBROUS HISTIOCYTOMA: A CASE REPORT
791
Myxoinflammatory fibroblastic sarcoma showing t(2;6)(q31;p21.3) as a sole cytogenetic abnormality
792
Myxoinflammatory fibroblastic sarcoma with complex supernumerary ring chromosomes composed of chromosome 3 segments
793
Myxoinflammatory fibroblastic sarcoma: a case report
794
Myxoma Immediately above the Junction of the Inferior Vena Cava and the Right Atrium: A Rare Cause of Budd-Chiari Syndrome
795
Myxoma in a Terrier Dog : a Case Report
796
Myxoma of the Aortic Valve
797
Myxoma of the aortic valve
798
Myxoma of the cornea
799
Myxoma of the right and left ventricles,A Case Report
800
Myxoma of the Superior Vena Cava Origin Presented as a Right Atrial Mass
801
Myxoma producing right-sided inflow and outflow obstruction
802
Myxoma Virus Immunomodulatory Protein M156R is a Structural Mimic of Eukaryotic Translation Initiation Factor eIF2α
803
Myxomatous embolization resulting in unilateral amaurosis
804
Myxomatous meningeal tumour: a case of “metastatic” cardiac myxoma
805
Myxomatous mitral valve disease and related entities: The role of matrix in valvular heart disease
806
Myxomycetes from Trabzon and Giresun Provinces (Turkey)
807
Myxomycetes in soil
808
Myxomycetes in soil
809
Myxopapillary Ependymoma of the Filum Terminale: Treatment and Outcome in 11 Cases
810
Myxopapillary ependymoma of the fourth ventricle
811
Myxopyronin B analogs as inhibitors of RNA polymerase, synthesis and biological evaluation
812
Myxosporeans (Phylum Myxozoa) Parasitic on Some Fishes from Tigris River at North, Mid and South of Baghdad Province, Iraq
813
Myxovirescin analogues via macrocyclic ring–closing metathesis
814
Mμ and D2 Receptor Antisense Oligonucleotides Injected in Nucleus Accumbens Suppress High Alcohol Intake in Genetic Drinking HEP Rats
815
Mω considered as a programming language Original Research Article
816
N
817
N - Commuting Maps on Semiprime Rings
818
N – Topological Space and Its Applications in Artificial Neural Networks
819
n + p → d + γ in effective field theory Original Research Article
820
N = 1 dual string pairs and gaugino condensation Original Research Article
821
N = 1 dual string pairs and their massless spectra Original Research Article
822
N = 1 dualities of SO and USp gauge theories and T-duality of string theory Original Research Article
823
N = 1 heterotic / M-theory duality and Joyce manifolds Original Research Article
824
N = 1 string duality
825
N = 1 super-Chern-Simons coupled to parity-preserving matter from Atiyah-Ward space-time
826
N = 1 supergravity BPS domain walls on Kähler–Ricci soliton
827
N = 1 superstring in 2 + 2 dimensions Original Research Article
828
N = 1 supersymmetric cosmic strings
829
N = 1 supersymmetric extension of the QCD effective action
830
N = 1 supersymmetric SU(4) × SU(2)L × SU (2)R effective theory from the weakly coupled heterotic superstring Original Research Article
831
N = 1 supersymmetry and the three-loop anomalous dimension for the chiral superfield Original Research Article
832
N = 1 supersymmetry and the three-loop gauge β-function
833
N = 1 super-τ3QED from Atiyah-Ward space-time
834
N = 1, D = 2 supermembrane in the coset approach
835
N = 1, D = 6 supergravity: Duality and non-minimal couplings Original Research Article
836
N = 2 curves and a Coulomb phase in N = 1 SUSY gauge theories with adjoint and fundamental matters
837
N = 2 extremal black holes and intersecting branes
838
N = 2 gauge theories on systems of fractional D3/D7-branes Original Research A
839
N = 2 heterotic string threshold correction, K3 surface and generalized Kac-Moody superalgebra
840
N = 2 heterotic superstring and its dual theory in five dimensions Original Research Article
841
N = 2 local and N = 4 non-local reductions of supersymmetric KP hierarchy in N = 2 superspace Original Research Article
842
N = 2 moduli spaces and N = 1 dualities for SO(nc) and USp(2nc) super-QCD Original Research Article
843
N = 2 rigid supersymmetry with gauged central charge Original Research Article
844
N = 2 super W∞ algebra and its nonlinear realization through super KP formulation
845
N = 2 super Yang-Mills and subgroups of SL(2,Z) Original Research Article
846
N = 2 super Yang-Mills low-energy effective action at two loops
847
N = 2 superconformal field theory with ADE global symmetry on a D3-brane probe Original Research Article
848
N = 2 supergravity Lagrangians with vector-tensor multiplets Original Research Article
849
N = 2 supersymmetric Calabi-Yau hypersurface sigma-models on curved two-dimensions
850
N = 2 supersymmetric gauge theories, branes and orientifolds Original Research Article
851
N = 2 Supersymmetric QCD and integrable spin chains: rational case Nf < 2Nc
852
N = 2 supersymmetry and Bailey pairs
853
N = 2 supersymmetry in a Chern-Simons system with the magnetic moment interaction
854
N = 2 supersymmetry of higher superspin massless theories
855
N = 2 topological Yang-Mills theories and Donaldsonʹs polynomials
856
N = 2 Type I-heterotic duality and higher derivative F-terms
857
N = 2 Type I-heterotic duality and higher derivative F-terms [Phys. Lett. B 395 (1997) 42]
858
N = 2 type II-heterotic duality and higher-derivative F-terms Original Research Article
859
N = 2 worldsheet instantons yield cubic self-dual Yang-Mills
860
N = 4 super NLS-mKdV hierarchies
861
N = 4 SYM on ∑ × S2 and its topological reduction Original Research Article
862
N = 4 topological strings Original Research Article
863
N = 4: a unifying framework for 2d topological gravity, cM ≤ 1 string theory and constrained topological sigma model
864
N = 8 BPS black holes with 12 or 14 supersymmetry and solvable Lie algebra decompositions Original Research Article
865
N = 8 gaugings revisited: an exhaustive classification Original Research Article
866
N → Δ electroproduction results from ELSA
867
N 2H +(1-0) survey of massive molecular cloud cores
868
n -3 Fatty acids plus oleic acid and vitamin supplemented milk consumption reduces total and LDL cholesterol, homocysteine and levels of endothelial adhesion molecules in healthy humans.
869
N Acetyl Cysteine, A novel Remedy for Poly Cystic Ovarian Syndrome
870
N Acetyl Cysteine, A novel Remedy for Poly Cystic Ovarian Syndrome
871
n advanced fuzzy controller
872
N and C mineralization in soil amended with the N immobilization inhibitor, methionine sulphoximine
873
N and C mineralization in soil amended with the N immobilization inhibitor, methionine sulphoximine
874
N- and C-terminal modifications of negamycin
875
N and C-terminal Sub-regions in the c-Myc Transactivation Region and their Joint Role in Creating Versatility in Folding and Binding Original Research Article
876
N- and Mo-doping Bi2WO6 in photocatalytic water splitting
877
N and N,S-doped TiO2 photocatalysts and their activity in NOx oxidation
878
N and p doped poly(3,4-ethylenedioxythiophene) electrode materials for symmetric redox supercapacitors
879
N and P dynamics in the litter layer and soil of Mexican semi-arid forests, state of Morelos
880
N and P leaching and microbial contamination from intensively managed pasture and cut sward on sandy soil in Finland
881
n- and p-Channel field-effect transistors based on diquinoxalinoTTF derivatives
882
N and p-type doping of PECVD a-SiC:H obtained under “silane starving plasma” condition with and without hydrogen dilution
883
N atoms recombination on a silica surface: A global theoretical approach
884
N balance as an indicator of N leaching in an oilseed rape – winter wheat – winter barley rotation
885
N biochemical diversity as a factor of soil diversity
886
N biochemical diversity as a factor of soil diversity
887
N -BIT PARITY NEURAL NETWORKS WITH MINIMUM NUMBER OF THRESHOLD NEURONS
888
N budget as water quality management tool in closed aquatic mesocosms
889
N -carboxymethyllysine formation by direct addition of glyoxal to lysine during the Maillard reaction
890
N deficiency in a well-oxygenated cold bottom water over the Bering Sea shelf: influence of sedimentary denitrification
891
N Degrees of Separation: Influences of Dynamic Programming on Computer Science
892
N dopant induced antiferromagnetism in anatase TiO2 : First principle study
893
N dynamics and sources of N2O production following pig slurry application to a loamy soil
894
N dynamics in the rhizosphere of Pinus ponderosa seedlings
895
N dynamics in the rhizosphere of Pinus ponderosa seedlings
896
N EWTON : An Interactive Environment for Exploring Mathematics
897
n examination of strategic goals and management practices of Russian enterprises
898
N fluxes in an agricultural catchment under monsoon climate: A budget approach at different scales
899
n Focus: Featured Articles in This Monthʹs Animal Behaviour
900
n fuzzy type theory
901
N -FUZZY UP-ALGEBRAS AND ITS LEVEL SUBSETS
902
N identical particles under quantum confinement: a many-body dimensional perturbation theory approach
903
n improved family of ZVS-PWM active-clamping DC-to-DC converters
904
N incorporation and electronic structure in N-doped TiO2(1 1 0) rutile
905
N incorporation, composition and electronic structure in N-doped TiO2(0 0 1) anatase epitaxial films grown on LaAlO3(0 0 1)
906
N leaching to groundwater from dairy production involving grazing over the winter on a clay-loam soil Original Research Article
907
N mineralization and nitrate leaching from vegetable crop residues under field conditions: a model evaluation
908
N mineralization and nitrate leaching from vegetable crop residues under field conditions: a model evaluation
909
n observation instrument for assessment of work technique n patient transfer tasks
910
N parallel queueing systems with server breakdown and repair
911
n properties of solutions to the improved modified Boussinesq equation
912
n search of practical applications: A public services research agenda for university libraries
913
n search of the liquidity effect in Ukraine
914
n the frame of globalization and sustainability, process intensification, a path to the future of chemical and process engineering (molecules into money
915
n the second part of Hilbertʹs 16th problem
916
n the well-foundedness of adequate orders used for construction of complete unfolding prefixes
917
n- to p- type carrier reversal in nanocrystalline indium doped ZnO thin film gas sensors
918
N umerical analyses of the impact of plates for thermal stratification inside a storage tank with upper and lower inlet flows
919
N uptake and yield of wheat as influenced by integrated use of organic and mineral nitrogen
920
N- versus P-co-ordination for N–B and P–B bonded BH3 adducts for various phosphinamine ligands – An experimental and computational study
921
n vivo motion of the rectus femoris muscle after tendon transfer surgery
922
N- vs O-Coordination in cyclomanganation of 1,5-diaryl-3-(2-pyridyl)pentane-1,5-diones and 3-(2-pyridyl)chalcones; cyclomanganation at saturated carbon and the crystal structure of [1,5-diphenyl-κC2-3-(2-pyridyl- κN)pentan-2-yl-κC2-1,5-dione-κO1κO5]tetrac
923
N- WAY COMPACT ULTRA-WIDE BAND EQUAL AND UNEQUAL SPLIT TAPERED TRANSMISSION LINES WILKINSON POWER DIVIDER
924
n -weak amenability of a certain class of function spaces
925
n α-solvable fundamental groups
926
N + 1 redundancy on ATCA instrumentation for Nuclear Fusion
927
N-((8-Hydroxy-5-substituted-quinolin-7-yl)(phenyl)methyl)-2-phenyloxy/amino-acetamide inhibitors of ADAMTS-5 (Aggrecanase-2)
928
N-(1,2-Diphenylethyl)piperazines: A new class of dual serotonin/noradrenaline reuptake inhibitor
929
N-(15,16-Dihydroxylinoleoyl)-glutamine and N-(15,16-epoxylinoleoyl)-glutamine isolated from oral secretions of lepidopteran larvae
930
N-(1-Benzylpyrrolidin-3-yl)arylbenzamides as potent and selective human dopamine D4 antagonists
931
N-(1-Carboxyethyl)alanine (alanopine), a new non-sugar component of lipopolysaccharides of Providencia and Proteus
932
N-(1-phenyl-2-benzimidazolyl)-N′-phenylurea derivatives as potent in hibitors of acylcoa:cholesterol acyltransferase (ACAT)
933
N-(2-(2-pyridyl)ethyl)chitosan: Synthesis, characterization and sorption properties
934
N-(2-(4-hydroxyphenyl)ethyl)-4-chlorocinnamide: A novel antagonist at the 1 /2B NMDA receptor subtype
935
N-(2,2-Dimethyl-2-(2-nitrophenyl)acetyl)-4-aminocyclophosphamide as a potential bioreductively activated prodrug of phosphoramide mustard
936
N-(2,2-Diphenylvinyl)-N,N′-diphenylbenzidine-based derivatives as hole-transporting glass-forming materials
937
N-(2′,5′-di-t-butylphenyl)-4-ethoxy-1,8-naphthalimide: A new fluorophore highly efficient for fast neutrons/gamma-rays discrimination in liquid media
938
N-(2′,5′-di-t-butylphenyl)-4-ethoxy-1,8-naphthalimide: A new fluorophore highly efficient for fast neutrons/gamma-rays discrimination in liquid media
939
N-(2-Acetamido-2-de­­oxy-β-D-gluco­pyranos­yl)-N-(3-azido­prop­yl)-O-methyl­hydroxyl­amine
940
N-(2-Alkoxyphenyl)-substituted double rhodanine indoline dyes for zinc oxide dye-sensitized solar cell
941
N-(2-Amino-phenyl)-4-(heteroarylmethyl)-benzamides as new histone deacetylase inhibitors
942
N-(2-Anthracene)methacrylamide: a new fluorogenic probe molecule for monitoring in situ the radiation-induced polymerization of methyl methacrylate in bulk and in solution
943
N-(2-Benzoylphenyl)benzamido nickel(II) complexes and polymerization reactivity
944
N-(2-biphenylenyl)-4-[2′-phenylethynyl]phthalimide—new monomer synthesis, cure and thermal properties of resulting high temperature polymer
945
N-(2-bromotetrafluoroethyl) derivatives of five-membered nitrogen-containing heterocycles
946
N-(2-Carboxyethyl)chitosans: regioselective synthesis, characterisation and protolytic equilibria Original Research Article
947
N(2D) in nitrogen afterglow
948
N-(2-formyl-1-methylimidazol-4-yl)-2,2-dimethylpropanamide: a versatile reagent for preparing imidazole-amine ligands with variable second-coordination spheres
949
N-(2-hydroxypropyl)-3-trimethylammonium chitosan-poly(ɛ-caprolactone) copolymers and their antibacterial activity
950
N-(2-Hydroxypropyl)formamide and N-(2-hydroxyethyl)-N-methylformamide as two new plasticizers for thermoplastic starch
951
N-(2-Hydroxypropyl)formamide and N-(2-hydroxyethyl)-N-methylformamide as two new plasticizers for thermoplastic starch
952
N-(2-pyridylmethyl)-L-histidine functionalized Fe3O4 magnetic nanoparticles as an efficient catalyst for synthesis of β-amino ketones
953
N-(2-pyrrolidinylmethyl)benzoxazine-8-carboxamides exhibiting high affinities for All of D2, 5-HT1 A, and 5-HT2 receptors
954
N-(3-(4-Hydroxyphenyl)-propenoyl)-amino acid tryptamides as SIRT2 inhibitors
955
N-(3-(Phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: Structure, synthesis and SAR
956
N-(3-acyloxy-2-benzylpropyl)-N′-(4-hydroxy-3-methoxybenzyl)thiourea derivatives as potent vanilloid receptor agonists and analgesics Original Research Article
957
N-(3-Acyloxy-2-Benzylpropyl)-N′-Dihydroxytetrahydrobenzazepine and Tetrahydroisoquinoline Thiourea Analogues as Vanilloid Receptor Ligands Original Research Article
958
N-(3-Benzo[b]thienyl)iminophosphoranes toward the Synthesis of Benzo[b]thieno[3,2-b]pyridines: Reactivity and Alternative Regioselectivity with α,β-unsaturated Ketones and Aldehydes
959
N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3
960
N-(3-Iodophenyl)trozamicol (IPHT) and Related Inhibitors of Vesicular Acetylcholine Transport: Synthesis and Preliminary Biological Characterization
961
N-(3-Phenylsulfonyl-3-piperidinoyl)-phenylalanine derivatives as potent, selective VLA-4 antagonists
962
N-(3-Triethoxysilylpropyl)-4-(isothiocyanatomethyl)-cyclohexane-1-carboxamide (TPICC): A heterobifunctional reagent for immobilization of biomolecules on glass surface
963
N-(3-Triethoxysilylpropyl)-4-(N′-maleimidylmethyl)cyclohexanamide (TPMC): A heterobifunctional reagent for immobilization of oligonucleotides on glass surface
964
N-(3-Trifluoroethanesulfonyloxypropyl)anthraquinone- 2-carboxamide: A New Heterobifunctional Reagent for Immobilization of Biomolecules on a Variety of Polymer Surfaces
965
N-(4-(4-Chlorophenyl)Thiazol-2-yl)-2-(2-Phenylacetamido) Acetamide Derivatives as Potential Anticancer Agents: Synthesis and Cytotoxicity Evaluation
966
N-(4-(di-tert-butyl[18F]fluorosilyl)benzyl)-2-hydroxy-N,N-dimethylethylammonium bromide ([18F]SiFAN+Br−): A novel lead compound for the development of hydrophilic SiFA-based prosthetic groups for 18F-labeling
967
N-(4-(quinazolin-2-yl)phenyl)benzamide derivatives with potent anti-angiogenesis activities: synthesis and evaluation
968
N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors
969
N-(4-Bromobenzoyl)-S,S-dimethyliminosulfurane, a potent dermal penetration enhancer
970
N-(4-hydroxyphenyl)retinamide (4-HPR) modulates GADD45 expression in radiosensitive bladder cancer cell lines
971
N-(4-Hydroxyphenyl)retinamide induced differentiation with repression of telomerase and cell cycle to increase interferon-γ sensitivity for apoptosis in human glioblastoma cells
972
N-(4-hydroxyphenyl)retinamide-induced death in human lymphoblastoid cells: 50 kb DNA breakage as a means of distinguishing apoptosis from necrosis
973
N-(5-Chloro-2-(hydroxymethyl)-N-alkyl-arylsulfonamides as γ-secretase inhibitors
974
N-(5-Mercapto-1,3,4-Thiadiazol-2-yl)-2-Phenylacetamide Derivatives: Synthesis and In-vitro Cytotoxicity Evaluation as Potential Anticancer Agents
975
N-(5-substituted) thiophene-2-alkylsulfonamides as potent inhibitors of 5-lipoxygenase Original Research Article
976
N-(6- F-18Fluorohexyl)-N-Methylpropargylamine: A Fluorine-18-Labeled Monoamine Oxidase B Inhibitor for Potential Use in PET Studies
977
N-(6,7-Dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-d-aspartate receptor antagonists for the treatment of pain
978
N-(6-Methyl-2-pyridyl)acrylamide: a case of amide hydrolysis without the assistance of acid or base in the synthesis of water-driven H-bonded polymeric chains
979
N(7)-protonation-induced conformational flipping in hypermodified nucleic acid base N6-(N-glycylcarbonyl) adenine
980
N-(Aryl)-4-(azolylethyl)thiazole-5-carboxamides: Novel potent inhibitors of VEGF receptors I and II
981
N-(Arylacetyl)-biphenylalanines as Potent VLA-4 Antagonists
982
N-(Benzoyloxy)amines: an investigation of their thermal stability, synthesis, and incorporation into novel peptide constructs
983
N-(carbobenzyloxy)isatin: A slow binding α-keto lactam inhibitor of α-chymotrypsin
984
N-(Cyclohexanecarboxyl)-O-Phospho-l-Serine, a Minimal Substrate for the Dual-Specificity Protein Phosphatase IphP
985
N-(Diethoxyphosphoryl)-O-benzylhydroxylamine—a convenient substrate for the synthesis of N-substituted O-benzylhydroxylamines
986
N-(ethoxycarbonyl)ferrocenecarboxamide: Synthesis and use as the pronucleophile in the Mitsunobu reaction
987
N-(Hydroxyaminocarbonyl)phenylalanine: a novel class of inhibitor for carboxypeptidase A Original Research Article
988
N-(Indol-3-ylglyoxylyl)piperidines: high affinity agonists of human GABA-A receptors containing the α1 subunit
989
N(k)-quasi Einstein manifolds satisfying certain conditions
990
N(k)-Quasi Einstein manifolds satisfying certain curvature conditions
991
N-(n-benzylpiperidin-4-yl)-2-[18f]fluorobenzamide: a potential ligand for pet imaging of breast cancer
992
N-(o-Aminophenyl)-2-oxy-4-methoxybenzophenoneimine – Si-chelation by a tridentate ONN ligand system versus benzimidazoline formation
993
N(omega) and (delta)(omega) dibaryons in a SU(3) chiral quark model
994
N-(p-Ethynylbenzoyl) derivatives of amino acid and dipeptide methyl esters – Synthesis and structural study
995
N-(Phenylselenomethyl)phthalimide as new reagent for mild protection of alcohols as Pim-ethers
996
N-(phenylsulfonyl)-glycine — A new contaminant in sewage- and surface water
997
N-(Piperidinomethyl)-3-[(pyridylidene)amino]isatin: A new and effective acid corrosion inhibitor for mild steel
998
N-(Propargyl)diazenecarboxamides for ‘click’ conjugation and their 1,3-dipolar cycloadditions with azidoalkylamines in the presence of Cu(II)
999
N-(Pyrimidin-4-yl) and N-(Pyridin-2-yl) phenylalanine derivatives as VLA-4 integrin antagonists
1000
N-(Quinuclidin-3-yl)-2-(1-methyl-1H-indol-3-yl)-2-oxo-acetamide: a high affinity 5-HT3 receptor partial agonist
بازگشت